Velphoro (sucroferric oxyhydroxide) NDC 49230-645

NDC codes

FDA NDC Directory

Product NDC (as listed)49230-645Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49230-0645Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49230-645-51	49230064551	1 BOTTLE in 1 CARTON (49230-645-51) / 90 TABLET, CHEWABLE in 1 BOTTLEMarketed from Nov 27, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Velphoro
Generic name (nonproprietary): sucroferric oxyhydroxide
Active ingredients: Ferric oxyhydroxide — 500 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: Fresenius Medical Care Renal Therapies Group, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 205109
Marketing start: Nov 27, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 49230-645_4e6c954e-7710-efc7-e063-6394a90a6dc2SPL ID 4e6c954e-7710-efc7-e063-6394a90a6dc2SPL set ID 237da26c-f38c-4faa-93ad-735e71c9d0c1RxCUI 1484289, 1484296UNII 87PZU03K0KUPC 0349230645514
Pharmacologic class: Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N449230064551 followed by a unit qualifier and the quantity

Package 49230-0645-51. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2026.

Indications (excerpt from the label)

Velphoro is indicated for the control of serum phosphorus levels in adults and pediatric patients 9 years of age and older with chronic kidney disease (CKD) on dialysis. Velphoro is a phosphate binder indicated for the control of serum phosphorus levels in adult and pediatric patients 9 years of age and older with chronic kidney disease on dialysis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)